Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
3.31
Dollar change
+0.01
Percentage change
0.30
%
IndexRUT P/E- EPS (ttm)-0.32 Insider Own18.03% Shs Outstand544.91M Perf Week-3.78%
Market Cap1.81B Forward P/E- EPS next Y-0.12 Insider Trans0.00% Shs Float447.58M Perf Month59.90%
Income-184.13M PEG- EPS next Q-0.10 Inst Own55.15% Short Float11.38% Perf Quarter44.54%
Sales0.24M P/S7531.08 EPS this Y-1.56% Inst Trans-1.67% Short Ratio4.53 Perf Half Y52.53%
Book/sh0.46 P/B7.27 EPS next Y63.59% ROA-62.99% Short Interest50.95M Perf Year42.06%
Cash/sh0.61 P/C5.40 EPS next 5Y5.00% ROE-112.29% 52W Range1.64 - 3.73 Perf YTD56.87%
Dividend Est.- P/FCF- EPS past 5Y-16.08% ROI-64.38% 52W High-11.38% Beta0.61
Dividend TTM- Quick Ratio3.16 Sales past 5Y46.26% Gross Margin- 52W Low101.83% ATR (14)0.27
Dividend Ex-Date- Current Ratio3.16 EPS Y/Y TTM11.31% Oper. Margin-81832.91% RSI (14)67.11 Volatility4.76% 10.73%
Employees141 Debt/Eq0.35 Sales Y/Y TTM-60.23% Profit Margin-77691.14% Recom1.17 Target Price5.08
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q16.36% Payout- Rel Volume0.95 Prev Close3.30
Sales Surprise-71.78% EPS Surprise14.29% Sales Q/Q-77.67% EarningsFeb 28 BMO Avg Volume11.24M Price3.31
SMA2029.55% SMA5048.82% SMA20040.10% Trades Volume10,654,749 Change0.30%
Date Action Analyst Rating Change Price Target Change
Mar-15-24Reiterated Needham Buy $4 → $5
Sep-12-23Upgrade Goldman Neutral → Buy $4
Mar-28-23Initiated Goldman Neutral $3
Oct-28-22Initiated Wedbush Outperform $5
Jul-28-22Resumed B. Riley Securities Buy $4
Nov-02-21Initiated Robert W. Baird Outperform $4
Feb-18-21Resumed B. Riley Securities Buy $4
Aug-03-20Initiated Stifel Buy $3
Nov-19-19Resumed B. Riley FBR Buy $4
Sep-03-19Initiated H.C. Wainwright Buy $4
Mar-19-24 09:07AM
Mar-15-24 03:50PM
01:29PM
10:47AM
08:57AM
05:00AM Loading…
05:00AM
Mar-14-24 03:54PM
Mar-13-24 10:48AM
Mar-12-24 12:28PM
Mar-08-24 04:20PM
Feb-28-24 07:05AM
Feb-22-24 04:30PM
Feb-14-24 04:30PM
Jan-18-24 04:30PM
Jan-12-24 08:30AM
04:30PM Loading…
Dec-21-23 04:30PM
Dec-11-23 04:15PM
Dec-06-23 08:00AM
Dec-04-23 05:00AM
Nov-28-23 08:00AM
Nov-16-23 04:30PM
Nov-07-23 04:30PM
Nov-02-23 09:00AM
08:00AM
Oct-26-23 04:30PM
Oct-19-23 04:30PM
Oct-12-23 03:26PM
Sep-29-23 08:00AM
Sep-11-23 04:30PM
Sep-07-23 08:00AM
04:30PM Loading…
Sep-05-23 04:30PM
Aug-22-23 08:00AM
Aug-21-23 08:00AM
Aug-17-23 04:30PM
Aug-03-23 04:05PM
Jul-27-23 04:30PM
Jul-20-23 04:30PM
Jun-29-23 08:30AM
Jun-22-23 04:30PM
Jun-20-23 09:00AM
Jun-13-23 09:00AM
Jun-12-23 08:00AM
Jun-07-23 04:30PM
Jun-06-23 04:30PM
Jun-02-23 03:30PM
May-25-23 05:02PM
May-18-23 04:30PM
May-11-23 10:02AM
08:00AM
May-04-23 04:30PM
Apr-26-23 10:05AM
Apr-20-23 04:30PM
Apr-12-23 04:40PM
Mar-16-23 05:45PM
04:05PM
Mar-09-23 04:30PM
Feb-16-23 04:30PM
Feb-03-23 01:19PM
Jan-19-23 04:30PM
Jan-12-23 07:30AM
Jan-11-23 07:30AM
Jan-10-23 04:30PM
Jan-05-23 11:15PM
Jan-04-23 04:19PM
06:55AM
Jan-03-23 04:30PM
Dec-22-22 04:30PM
Dec-13-22 11:10AM
Dec-12-22 08:00AM
Dec-08-22 11:30AM
Dec-07-22 11:30AM
Dec-04-22 05:19PM
Nov-17-22 04:30PM
Nov-07-22 04:30PM
Nov-04-22 12:00AM
Nov-03-22 09:25AM
09:01AM
08:00AM
Oct-27-22 04:30PM
Oct-25-22 06:15AM
Oct-24-22 09:40AM
Oct-20-22 04:30PM
Sep-22-22 04:30PM
Sep-14-22 06:43AM
Sep-08-22 04:15PM
Sep-01-22 04:30PM
Aug-31-22 04:55PM
04:33PM
Aug-22-22 04:15PM
09:11AM
Aug-18-22 04:30PM
Aug-12-22 11:21AM
Aug-11-22 11:00PM
05:24PM
04:05PM
Aug-10-22 02:54PM
Aug-09-22 12:14PM
12:03PM
Aug-04-22 04:30PM
12:00PM
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Farrell Elizabeth G.DirectorAug 24 '23Buy2.286,60715,0647,407Aug 24 08:52 PM
O'Farrell Elizabeth G.DirectorAug 24 '23Buy2.286,57915,00026,220Aug 24 08:52 PM
LAWLIS V BRYANDirectorMay 11 '23Option Exercise1.1035,00038,50035,000May 11 09:01 PM
LAWLIS V BRYANDirectorMay 11 '23Sale3.0035,000105,0000May 11 09:01 PM
Molineaux SusanDirectorMay 01 '23Option Exercise1.1035,00038,50035,000May 01 09:20 PM
Molineaux SusanDirectorMay 01 '23Sale2.4835,00086,8000May 01 09:20 PM